Trial Profile

Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 01 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tadalafil (Primary)
Indications Cerebrovascular disorders
Focus Proof of concept; Therapeutic Use
Acronyms PASTIS

Most Recent Events

04 Aug 2022 Primary endpoint (Change in local cerebral blood flow within deep brain nuclei and deep white matter) has not been met, according to Results presented at the Alzheimer's Association International Conference 2022.
04 Aug 2022 Results presented at the Alzheimer's Association International Conference 2022
08 Feb 2019 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com